ReviewImmunological reviews2011

OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.

John Goulding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.